CN103554088B - 苯并二氮杂*化合物及药物组合物 - Google Patents

苯并二氮杂*化合物及药物组合物 Download PDF

Info

Publication number
CN103554088B
CN103554088B CN201310203728.XA CN201310203728A CN103554088B CN 103554088 B CN103554088 B CN 103554088B CN 201310203728 A CN201310203728 A CN 201310203728A CN 103554088 B CN103554088 B CN 103554088B
Authority
CN
China
Prior art keywords
ethyl
pyridin
dihydrobenzo
propoxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310203728.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103554088A (zh
Inventor
大岛邦生
押山孝
平良伸一
校条康宏
山边北斗
松村修二
植田昌孝
古贺康雄
田井国宪
中山直
小野川利幸
辻前贤司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN103554088A publication Critical patent/CN103554088A/zh
Application granted granted Critical
Publication of CN103554088B publication Critical patent/CN103554088B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201310203728.XA 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物 Expired - Fee Related CN103554088B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2008-041296 2008-02-22
JP2008041296 2008-02-22
JP2008227368 2008-09-04
JP2008-227368 2008-09-04
CN200980105883XA CN101952259B (zh) 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN200980105883XA Division CN101952259B (zh) 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物

Publications (2)

Publication Number Publication Date
CN103554088A CN103554088A (zh) 2014-02-05
CN103554088B true CN103554088B (zh) 2016-02-24

Family

ID=40600203

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200980105883XA Expired - Fee Related CN101952259B (zh) 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物
CN201310203728.XA Expired - Fee Related CN103554088B (zh) 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN200980105883XA Expired - Fee Related CN101952259B (zh) 2008-02-22 2009-02-20 苯并二氮杂*化合物及药物组合物

Country Status (26)

Country Link
US (2) US8338406B2 (enExample)
EP (1) EP2254873B1 (enExample)
JP (1) JP5355582B2 (enExample)
KR (1) KR101332948B1 (enExample)
CN (2) CN101952259B (enExample)
AR (1) AR070449A1 (enExample)
AU (1) AU2009216079B2 (enExample)
BR (1) BRPI0908132A2 (enExample)
CA (1) CA2715872A1 (enExample)
CO (1) CO6300950A2 (enExample)
CY (1) CY1115220T1 (enExample)
DK (1) DK2254873T3 (enExample)
ES (1) ES2494366T3 (enExample)
HR (1) HRP20140796T1 (enExample)
IL (1) IL207276A (enExample)
MX (1) MX2010009269A (enExample)
MY (1) MY156226A (enExample)
NZ (1) NZ587157A (enExample)
PL (1) PL2254873T3 (enExample)
PT (1) PT2254873E (enExample)
RU (1) RU2496775C2 (enExample)
SI (1) SI2254873T1 (enExample)
TW (1) TWI413522B (enExample)
UA (1) UA103018C2 (enExample)
WO (1) WO2009104819A1 (enExample)
ZA (1) ZA201005469B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2254873B1 (en) 2008-02-22 2014-06-04 Otsuka Pharmaceutical Co., Ltd. Benzodiazepine compound and pharmaceutical composition
KR20120065360A (ko) 2009-08-21 2012-06-20 오츠카 세이야쿠 가부시키가이샤 벤조[b][1,4]디아제핀-2,4-디온 화합물의 제조 방법
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
EP2712655B1 (en) * 2011-04-28 2019-12-18 The Broad Institute, Inc. Inhibitors of histone deacetylase
EP2780344A1 (en) 2011-11-15 2014-09-24 Xention Limited Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
JP6337255B2 (ja) 2012-07-27 2018-06-06 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. ヒストンデアセチラーゼの阻害剤
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JOP20190086A1 (ar) * 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA038455B1 (ru) * 2016-10-26 2021-08-31 Новартис Аг Новые производные нафтиридинона и их применение в лечении аритмии
IL273428B2 (en) 2017-09-22 2023-09-01 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
BR112020008851A2 (pt) 2017-11-06 2020-10-20 Jubilant Prodel LLC composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
JP7368369B2 (ja) 2017-11-24 2023-10-24 ジュビラント・エピスクライブ・エルエルシー Prmt5阻害剤としてのヘテロ環式化合物
US12128018B2 (en) 2018-01-12 2024-10-29 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
JP7279063B6 (ja) 2018-03-13 2024-02-15 ジュビラント プローデル エルエルシー Pd1/pd-l1相互作用/活性化の阻害剤としての二環式化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
BE707667A (enExample) 1966-12-14 1968-06-07
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
JPH0296133A (ja) * 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
BR9200951A (pt) 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5691331A (en) 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
NZ532463A (en) * 2001-11-13 2007-02-23 Dimensional Pharm Inc Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
EP1585511B1 (en) 2002-12-20 2013-01-23 Amgen Inc. Asthma and allergic inflammation modulators
TWI329641B (en) 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
EP2254873B1 (en) 2008-02-22 2014-06-04 Otsuka Pharmaceutical Co., Ltd. Benzodiazepine compound and pharmaceutical composition

Also Published As

Publication number Publication date
JP5355582B2 (ja) 2013-11-27
US20130040941A1 (en) 2013-02-14
MX2010009269A (es) 2010-09-14
PL2254873T3 (pl) 2014-10-31
JP2011512324A (ja) 2011-04-21
CA2715872A1 (en) 2009-08-27
US8664217B2 (en) 2014-03-04
ZA201005469B (en) 2011-11-30
HK1145461A1 (en) 2011-04-21
HRP20140796T1 (hr) 2014-10-24
EP2254873B1 (en) 2014-06-04
AU2009216079A1 (en) 2009-08-27
ES2494366T3 (es) 2014-09-15
BRPI0908132A2 (pt) 2015-08-04
CN101952259A (zh) 2011-01-19
US8338406B2 (en) 2012-12-25
UA103018C2 (uk) 2013-09-10
CN101952259B (zh) 2013-07-03
MY156226A (en) 2016-01-29
WO2009104819A1 (en) 2009-08-27
NZ587157A (en) 2012-05-25
RU2496775C2 (ru) 2013-10-27
CY1115220T1 (el) 2017-01-04
TW200940067A (en) 2009-10-01
PT2254873E (pt) 2014-08-29
KR20100124781A (ko) 2010-11-29
DK2254873T3 (da) 2014-06-30
KR101332948B1 (ko) 2014-01-17
EP2254873A1 (en) 2010-12-01
US20100331317A1 (en) 2010-12-30
AU2009216079B2 (en) 2013-08-22
TWI413522B (zh) 2013-11-01
IL207276A0 (en) 2010-12-30
CO6300950A2 (es) 2011-07-21
CN103554088A (zh) 2014-02-05
RU2010138928A (ru) 2012-03-27
AR070449A1 (es) 2010-04-07
IL207276A (en) 2014-11-30
SI2254873T1 (sl) 2014-07-31

Similar Documents

Publication Publication Date Title
CN103554088B (zh) 苯并二氮杂*化合物及药物组合物
CN102482234B (zh) 含氮化合物及其用于治疗心房纤维性颤动的药物组合物
KR101605061B1 (ko) 칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체
JP2012184225A (ja) 医薬組成物
JP5669481B2 (ja) 医薬組成物
HK1145461B (en) Benzodiazepine compound and pharmaceutical composition
HK1167391B (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160224

Termination date: 20170220

CF01 Termination of patent right due to non-payment of annual fee